1148 related articles for article (PubMed ID: 18162465)
1. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide augments Chk2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase.
Yoda A; Toyoshima K; Watanabe Y; Onishi N; Hazaka Y; Tsukuda Y; Tsukada J; Kondo T; Tanaka Y; Minami Y
J Biol Chem; 2008 Jul; 283(27):18969-79. PubMed ID: 18482988
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of ATR and ATM in p53, Chk1, and histone H2AX phosphorylation in response to hyperoxia: ATR-dependent ATM activation.
Kulkarni A; Das KC
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L998-L1006. PubMed ID: 18344416
[TBL] [Abstract][Full Text] [Related]
4. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
[TBL] [Abstract][Full Text] [Related]
5. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
[TBL] [Abstract][Full Text] [Related]
6. hMSH2 recruits ATR to DNA damage sites for activation during DNA damage-induced apoptosis.
Pabla N; Ma Z; McIlhatton MA; Fishel R; Dong Z
J Biol Chem; 2011 Mar; 286(12):10411-8. PubMed ID: 21285353
[TBL] [Abstract][Full Text] [Related]
7. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
8. A positive role for c-Abl in Atm and Atr activation in DNA damage response.
Wang X; Zeng L; Wang J; Chau JF; Lai KP; Jia D; Poonepalli A; Hande MP; Liu H; He G; He L; Li B
Cell Death Differ; 2011 Jan; 18(1):5-15. PubMed ID: 20798688
[TBL] [Abstract][Full Text] [Related]
9. DNA damage induced by temozolomide signals to both ATM and ATR: role of the mismatch repair system.
Caporali S; Falcinelli S; Starace G; Russo MT; Bonmassar E; Jiricny J; D'Atri S
Mol Pharmacol; 2004 Sep; 66(3):478-91. PubMed ID: 15322239
[TBL] [Abstract][Full Text] [Related]
10. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.
Carlessi L; Buscemi G; Larson G; Hong Z; Wu JZ; Delia D
Mol Cancer Ther; 2007 Mar; 6(3):935-44. PubMed ID: 17363488
[TBL] [Abstract][Full Text] [Related]
12. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
13. Ataxia telangiectasia-mutated-Rad3-related DNA damage checkpoint signaling pathway triggered by hepatitis B virus infection.
Zhao F; Hou NB; Yang XL; He X; Liu Y; Zhang YH; Wei CW; Song T; Li L; Ma QJ; Zhong H
World J Gastroenterol; 2008 Oct; 14(40):6163-70. PubMed ID: 18985806
[TBL] [Abstract][Full Text] [Related]
14. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
[TBL] [Abstract][Full Text] [Related]
15. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage.
Reinhardt HC; Aslanian AS; Lees JA; Yaffe MB
Cancer Cell; 2007 Feb; 11(2):175-89. PubMed ID: 17292828
[TBL] [Abstract][Full Text] [Related]
16. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
17. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.
Jayachandran G; Ueda K; Wang B; Roth JA; Ji L
PLoS One; 2010 Aug; 5(8):e11994. PubMed ID: 20700484
[TBL] [Abstract][Full Text] [Related]
18. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
19. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
Jin J; Ang XL; Ye X; Livingstone M; Harper JW
J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic death induced by the cyclophosphamide analogue mafosfamide in human lymphoblastoid cells: contribution of DNA replication, transcription inhibition and Chk/p53 signaling.
Goldstein M; Roos WP; Kaina B
Toxicol Appl Pharmacol; 2008 May; 229(1):20-32. PubMed ID: 18289623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]